Earlier this week, the U.S. Department of Justice, representing the Food and Drug Administration and healthcare technology company Philips came to an agreement to no longer sell their sleep therapy or ...
Philips has reached a $1.1 billion agreement to settle claims from about 58,000 people stemming from its yearslong recall of home CPAP ventilators and sleep apnea machines. It’s a major milestone in ...
This article originally appeared in ProPublica. ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox. For ...
Adding additional wounds to Philips bruising few years dealing with its major recall of CPAP and BiPAP machines, a new issue has arisen in a swath of its CPAP machines not included in the 2021 notice.
Technology company Philips plans to cut an estimated 5% of its workforce, about 4,000 positions, due to losses caused by the recall of a sleep apnea product as well as supply chain issues, according ...
In the 11 years leading up to its 2021 recall of more than 5 million CPAP and BiPAP machines and ventilators, Philips received thousands of complaints about the devices—and failed to turn many of them ...
ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. Update, Nov. 25, 2024: On Nov. 22, hours after this article ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results